JP2008510812A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008510812A5 JP2008510812A5 JP2007530013A JP2007530013A JP2008510812A5 JP 2008510812 A5 JP2008510812 A5 JP 2008510812A5 JP 2007530013 A JP2007530013 A JP 2007530013A JP 2007530013 A JP2007530013 A JP 2007530013A JP 2008510812 A5 JP2008510812 A5 JP 2008510812A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- optionally
- alkoxy
- heterocycle
- ring
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 C*c1cc(C(C)(C)C)cc(C#N)c1S(C)=O Chemical compound C*c1cc(C(C)(C)C)cc(C#N)c1S(C)=O 0.000 description 6
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60425404P | 2004-08-25 | 2004-08-25 | |
| US60/604,254 | 2004-08-25 | ||
| PCT/US2005/029806 WO2006026235A1 (en) | 2004-08-25 | 2005-08-23 | Cytokine inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008510812A JP2008510812A (ja) | 2008-04-10 |
| JP2008510812A5 true JP2008510812A5 (enExample) | 2008-10-09 |
| JP5038139B2 JP5038139B2 (ja) | 2012-10-03 |
Family
ID=35355697
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007530013A Expired - Lifetime JP5038139B2 (ja) | 2004-08-25 | 2005-08-23 | サイトカインインヒビター |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7470692B2 (enExample) |
| EP (1) | EP1786801B1 (enExample) |
| JP (1) | JP5038139B2 (enExample) |
| AT (1) | ATE460410T1 (enExample) |
| CA (1) | CA2577446C (enExample) |
| DE (1) | DE602005019893D1 (enExample) |
| ES (1) | ES2339364T3 (enExample) |
| WO (1) | WO2006026235A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009132136A1 (en) * | 2008-04-23 | 2009-10-29 | Rigel Pharmaceuticals, Inc. | Carboxamide compounds for the treatment of metabolic disorders |
| CA2735208A1 (en) | 2008-09-02 | 2010-03-11 | Boehringer Ingelheim International Gmbh | Novel benzamides, production thereof, and use thereof as medicaments |
| CN102186818B (zh) * | 2008-09-02 | 2013-10-02 | 贝林格尔.英格海姆国际有限公司 | 作为p38 map 激酶抑制剂用于治疗呼吸系统疾病的7-(哌嗪-1-基甲基)-1h-吲哚-2-甲酸(苯基)-酰胺衍生物及其类似化合物 |
| EP2722329A1 (en) * | 2012-10-18 | 2014-04-23 | F. Hoffmann-La Roche AG | Indol-amide compounds as beta-amyloid inhbitors |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1497278B1 (en) | 2002-04-11 | 2010-05-26 | Boehringer Ingelheim Pharmaceuticals Inc. | Heterocyclic amide derivatives as cytokine inhibitors |
| US7078419B2 (en) * | 2003-03-10 | 2006-07-18 | Boehringer Ingelheim Pharmaceuticals, Inc. | Cytokine inhibitors |
-
2005
- 2005-08-23 WO PCT/US2005/029806 patent/WO2006026235A1/en not_active Ceased
- 2005-08-23 JP JP2007530013A patent/JP5038139B2/ja not_active Expired - Lifetime
- 2005-08-23 DE DE602005019893T patent/DE602005019893D1/de not_active Expired - Lifetime
- 2005-08-23 EP EP05786424A patent/EP1786801B1/en not_active Expired - Lifetime
- 2005-08-23 ES ES05786424T patent/ES2339364T3/es not_active Expired - Lifetime
- 2005-08-23 AT AT05786424T patent/ATE460410T1/de active
- 2005-08-23 CA CA2577446A patent/CA2577446C/en not_active Expired - Lifetime
- 2005-08-23 US US11/209,234 patent/US7470692B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007536231A5 (enExample) | ||
| AU2019416589B2 (en) | Heterocyclic compound intermediate, preparation method therefor and application thereof | |
| JP7792915B2 (ja) | Ｃｄ３８阻害薬 | |
| CA2903288C (en) | N-acyl-n'-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activities | |
| ES2197167T3 (es) | Imidazoles trisustituidos con multiples propiedades terapeuticas. | |
| ES2327940T3 (es) | 3-(4-heterociclil-1,2,3-triazol-1-il)-n-aril-benzamidas en calidad de inhibidores de la produccion de citocinas para el tratamiento de enfermedades inflamatorias cronicas. | |
| ES2601226T3 (es) | Derivados de imidazol como inhibidores de IDO | |
| EP3515887B1 (en) | Trpv4 antagonists | |
| US12421196B2 (en) | Inhibitors of NLRP3 inflammasome | |
| HRP20161010T1 (hr) | C5ar antagonisti | |
| RS56388B1 (sr) | Supstituisana jedinjenja benzaldehida i postupci za njihovu upotrebu u povećanju oksigenacije tkiva | |
| WO2001053267A1 (en) | Compounds exhibiting thrombopoietin receptor agonism | |
| KR20030008151A (ko) | 이미다조피리딘 및 이미다조피리미딘 항바이러스제 | |
| JP2010502628A (ja) | ホスファチジルイノシトール３−キナーゼの阻害剤として有用な５−（２−フリル）−１，３−チアゾール誘導体 | |
| WO2004106293A2 (en) | Oxazolyl - and thiazolyl - purine based tricyclic compounds. | |
| JPWO2009041447A1 (ja) | ５員複素環化合物 | |
| KR20180093974A (ko) | 브루톤 티로신 키나제의 억제제로서의 폴리사이클릭 화합물 | |
| JP2007513167A5 (enExample) | ||
| JP7012289B2 (ja) | ベンゾイルグリシン誘導体およびその作製および使用の方法 | |
| ES2325318T3 (es) | Derivados de triazol como inhibidores de la ciclooxigenasa (cox). | |
| JP2008509955A5 (enExample) | ||
| WO2023147468A1 (en) | N-oxide inhibitors of nlrp3 inflammasome | |
| JP2006514940A5 (enExample) | ||
| JP2001072660A (ja) | ＴＮＦ−α産生抑制剤および／またはＩＬ−１０産生促進剤 | |
| CN112243437A (zh) | 含丙烯酰基的核转运调节剂及其用途 |